President Trump promised that his deals with drug companies would bring down prescription drug prices.

But new findings show the opposite is happening.

As NBC News report, a new report found that companies that signed drug pricing deals with Trump have raised the cost of hundreds of medications and launched new ones at an average price of $353,000 a year.

Drugmakers have raised prices on hundreds of medications — including life-saving treatments for cancer and chronic illness — with some now costing hundreds of thousands of dollars per year. At the same time, these companies are reporting massive profits.

For patients, this isn’t abstract. It means higher costs, tougher choices, and less access to care.

Promises were made. Results are expected.

We are calling on President Trump, Congress, and the Department of Health and Human Services to take immediate action to lower drug prices, enforce real accountability, and ensure that patients—not corporations—come first.